FindTrial
Sign In

SC291

BIOLOGICAL2 trials

Sponsors

Sana Biotechnology

Conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisChronic Lymphocytic LeukemiaGranulomatous PolyangiitisLupus ErythematosusMicroscopic PolyangiitisNon Hodgkin LymphomaSLE (Systemic Lupus)Systemic Lupus Erythematosus

Phase 1

Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)
Active, not recruitingNCT05878184
Sana BiotechnologyChronic Lymphocytic Leukemia, Non Hodgkin Lymphoma
Start: 2023-05-02End: 2038-11-04Updated: 2025-10-02
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)
Active, not recruitingNCT06294236
Sana BiotechnologyAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Granulomatous Polyangiitis, Lupus Erythematosus +3
Start: 2024-04-29End: 2028-03-31Target: 7Updated: 2025-11-25

Related Papers

Hypoimmune CD19 CAR T cells evade allorejection in patients with cancer and autoimmune disease
Cell stem cell2025-08-134 citations